Effect of superoxide dismutase, catalase, chelating agents, and free radical scavengers on the toxicity of alloxan to isolated pancreatic islets in vitro

Free Radical Biology and Medicine

Volumn 26, Issue 9-10, 1999, Pages 1300-1304

  Jörns, Anne ^a   Tiedge, Markus ^a   Lenzen, Sigurd ^a   Munday, Rex ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b RUAKURA RESEARCH CENTRE   (New Zealand)

Author keywords

Alloxan toxicity to pancreatic islets; Catalase; Free radicals; Hydroxyl radical scavengers; Metal chelator; Superoxide dismutase

Indexed keywords

ALLOXAN; CATALASE; CHELATING AGENT; PENTETIC ACID; SCAVENGER; SUPEROXIDE DISMUTASE;

ALLOXAN DIABETES MELLITUS; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DIABETES MELLITUS; DRUG SCREENING; ENZYME ANALYSIS; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; SCAVENGING SYSTEM;

1-BUTANOL; ALLOXAN; ANIMALS; ANTIOXIDANTS; CATALASE; CHELATING AGENTS; DEFEROXAMINE; DIABETES MELLITUS, EXPERIMENTAL; DIMETHYL SULFOXIDE; FREE RADICAL SCAVENGERS; HYDROXYL RADICAL; ISLETS OF LANGERHANS; MICE; MICE, OBESE; SUPEROXIDE DISMUTASE;

ANIMALIA; LETHRINIDAE;

EID: 0345593812     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00325-6     Document Type: Article

References (38)

1. Webb J.L. Enzyme and metabolic inhibitors. 1966;Academic Press, New York.
2. Cooperstein, S. J.; Watkins, D. Action of toxic drugs on islet cells. In: Cooperstein, S. J.; Watkins, D., eds. The islet of Langerhans. New York: Academic Press; 1981:387-425.
3. Lenzen S., Panten U. Alloxan history and mechanism of action . Diabetologia. 31:1988;337-342.
4. Oberley L.W. Free radicals and diabetes. Free Radic. Biol. Med. 5:1988;113-124.
5. · formation . Biochem. Pharmacol. 38:1989;271-277.
6. Lenzen S., Munday R. Thiol-group reactivity, hydrophilicity and stability of alloxan, its reduction products and its N-methyl derivatives and a comparison with ninhydrin. Biochem. Pharmacol. 42:1991;1385-1391.
7. Zhang H., Zdolsek J.M., Brunk U.T. Effects of alloxan and reducing agents on macrophages in culture. Acta Path. Microbiol. Immunol. Scand. 99:1991;1038-1048.
8. Munday R. Dialuric acid autoxidation effects of transition metals on the reaction rate and on the generation of "active oxygen" species . Biochem. Pharmacol. 37:1988;409-413.
9. 3+-ethylenediaminetetraacetic acid. Chem. Pharm. Bull. 38:1990;993-997.
10. Sakurai K., Ogiso T. Inhibitory effect of glutathione on the generation of hydroxyl radicals in the reaction system of glutathione-alloxan. Chem. Pharm. Bull. 39:1991;737-742.
11. Asayama K., English D., Slonim A.E., Burr I.M. Chemiluminescence as an index of drug-induced free radical production in pancreatic islets. Diabetes. 33:1984;160-163.
12. Heikkila R.E., Bardon H., Cohen G. Prevention of alloxan-induced diabetes by ethanol administration. J. Pharm. Exp. Therap. 190:1974;501-506.
13. Heikkila R.E., Winston B., Cohen G., Barden H. Alloxan-induced diabetes - evidence for hydroxyl radical as a cytotoxic intermediate. Biochem. Pharmacol. 25:1976;1085-1092.
14. Grankvist K., Marklund S., Sehlin J., Täljedal I. Superoxide dismutase, catalase and scavengers of hydroxyl radical protect against the toxic action of alloxan on pancreatic islet cells in vitro. Biochem. J. 182:1979;17-25.
15. Abdel-Rahman M.S., Elrakhawy F.I., Iskander F.A. Protection of β cells against the effect of alloxan. Toxicol. Lett. 63:1992;155-164.
16. Grankvist K., Marklund S., Täljedal I. Superoxide dismutase is a prophylactic against alloxan diabetes. Nature. 294:1981;158-160.
17. Thaete L.G., Crouch R.K., Buse M.G., Spicer S.S. The protective role of copper-zinc superoxide dismutase against alloxan-induced diabetes: morphological aspects. Diabetologia. 28:1985;677-682.
18. Heikkila R.E., Cabbat F.S. Protection against alloxan-induced diabetes in mice by the hydroxyl radical scavenger dimethylurea. Eur. J. Pharmacol. 52:1978;57-60.
19. Heikkila R.E., Cabbat F.S. The prevention of alloxan-induced diabetes in mice by the iron-chelator detapac suggestion of a role for iron in the cytotoxic process . Experientia. 38:1982;378-379.
20. Tibaldi J., Benjamin J., Cabbat F.S., Heikkila R.E. Protection against alloxan-induced diabetes by various urea derivatives relationship between protective effects and reactivity with the hydroxyl radical . J. Pharmacol. Exp. Therap. 211:1979;415-418.
21. El-Hage A.N., Herman E.H., Ferrans V.J. Reduction in the diabetogenic effect of alloxan in mice by treatment with the antineoplastic agent ICRF-187. Res. Comm. Chem. Path. Pharmacol. 33:1981;509-523.
22. El-Hage A.N., Herman E.H., Yang G.C., Crouch R.K., Ferrans V.J. Mechanism of the protective activity of ICRF-187 against alloxan-induced diabetes in mice. Res. Comm. Chem. Path. Pharmacol. 52:1986;341-360.
23. Grankvist K., Marklund S.L. Opposite effects of two metal-chelator on alloxan-induced diabetes in mice. Life Sci. 33:1983;2535-2540.
24. Eizirik D.L., de Lúcio M.A., Boschero A.C., Hoffmann M.E. 1,10-Phenanthroline, a metal chelator, protects against alloxan - but not streptozotocin-induced diabetes. J. Free Radic. Biol. Med. 2:1986;189-192.
25. Halliwell B. Protection against tissue damage in vivo by desferrioxamine what is its mechanism of action? Free Radic. Biol. Med. 7:1989;645-651.
26. Buettner G.R. Activation of oxygen by metal complexes and its relevance to autoxidative processes in living systems. Bioelectrochem. Bioenerg. 18:1987;29-36.
27. Lazarow A., Patterson J.W. Protection against alloxan diabetes with cobalt, zinc, and ferrous iron. Anat. Rec. 109:1951;377.
28. Schauberger C.W., Thies R.L., Fischer L.J. Mechanism of protection from alloxan diabetes provided by n-butanol. J. Pharmacol. Exp. Therap. 201:1977;450-455.
29. Masukawa T., Nakanishi K. Involvement of blood glucose in the dimethylthiourea-induced protection against alloxan-induced diabetes. Jap. J. Pharmacol. 66:1994;159-161.
30. Kass E.H., Waisbren B.A. A method for consistent induction of chronic hyperglycemia with alloxan. Proc. Soc. Exp. Biol. Med. 60:1945;303-306.
31. Carter W.J., Younathan E.S. Studies on protection against the diabetogenic effect of alloxan by glucose. Proc. Soc. Exp. Biol. Med. 109:1962;611-612.
32. Jörns A., Munday R., Tiedge M., Lenzen S. Comparative toxicity of alloxan, N-alkylalloxans and ninhydrin to isolated pancreatic islets in vitro. J. Endocrinol. 155:1997;283-293.
33. Lernmark A. The preparation of, and studies on, free cell suspensions from mouse pancreatic islets. Diabetologia. 10:1974;431-438.
34. Anbar M., Neta P. A compilation of specific bimolecular rate constants for the reactions of hydrated electrons, hydrogen atoms and hydroxyl radicals with inorganic and organic compounds in aqueous solution. Int. J. Appl. Radiat. Isotopes. 18:1967;493-523.
35. Farhataziz; Ross, A. B. Selected specific rates of reactions of transients from water in aqueous solution. III. Hydroxyl radical and perhydroxyl radical and their radical ions. Nat. Stand. Ref. Data Ser., Nat. Bur. Stand.59:1977.
36. Fischer L.J., Hamburger S.A. Inhibition of alloxan action in isolated pancreatic islets by superoxide dismutase, catalase, and a metal chelator. Diabetes. 29:1980;213-216.
37. Tiedge M., Lortz S., Drinkgern J., Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes. 46:1997;1733-1742.
38. Crapo J.D., DeLong D.M., Sjostrom K., Hasler G.R., Drew R.T. The failure of aerosolized superoxide dismutase to modify pulmonary oxygen toxicity. Am. Rev. Resp. Dis. 115:1977;1027-1033.